[144] Viavi Solutions Inc. SEC Filing
Form 144 filed for Viavi Solutions Inc. (VIAV) shows a proposed sale of 13,115 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $146,560.13. The filing lists the number of outstanding shares as 223,245,915 and identifies the approximate date of sale as 08/29/2025 on NASDAQ. The securities were acquired on 08/28/2025 as restricted stock from the issuer, with payment dated 08/28/2025. The filer reports no securities sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes reliance possibilities for a Rule 10b5-1 trading plan if applicable. The issuer name and some filer contact details are not provided in the visible content.
Modulo 144 presentato per Viavi Solutions Inc. (VIAV) indica una proposta di vendita di 13.115 azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di 146.560,13 USD. La comunicazione riporta 223.245.915 azioni in circolazione e segnala come data approssimativa di vendita il 29/08/2025 sul NASDAQ. I titoli sono stati acquisiti il 28/08/2025 come azioni vincolate dall'emittente, con pagamento datato 28/08/2025. Il dichiarante segnala di non aver venduto titoli nei tre mesi precedenti. Nel documento 猫 inclusa la consueta dichiarazione secondo cui il venditore non 猫 a conoscenza di informazioni materiali avverse non divulgate e si menzionano eventuali dipendenze da un piano di negoziazione ai sensi della Regola 10b5-1, se applicabile. Nell'estratto visibile non sono riportati il nome completo dell'emittente e alcuni recapiti del dichiarante.
Formulario 144 presentado para Viavi Solutions Inc. (VIAV) muestra una propuesta de venta de 13.115 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de 146.560,13 USD. La presentaci贸n indica 223.245.915 acciones en circulaci贸n y se帽ala la fecha aproximada de venta como el 29/08/2025 en NASDAQ. Los valores fueron adquiridos el 28/08/2025 como acciones restringidas por el emisor, con pago con fecha 28/08/2025. El declarante informa que no ha vendido valores en los 煤ltimos tres meses. El expediente incluye la representaci贸n habitual de que el vendedor no conoce informaci贸n material adversa no divulgada y menciona la posible dependencia de un plan de negociaci贸n conforme a la Regla 10b5-1, si procede. En el contenido visible no aparecen el nombre del emisor ni algunos datos de contacto del declarante.
Viavi Solutions Inc. (VIAV)鞐� 雽�頃� 鞏戩嫕 144 鞝滌稖鞚� Morgan Stanley Smith Barney LLC毳� 韱淀暣 13,115欤� 氤错喌欤� 毵る弰毳� 鞝滌晥頄堨溂氅�, 齑� 鞁滉皜 臧�旃橂姅 146,560.13雼煬搿� 雮橅儉雮╇媹雼�. 鞝滌稖靹滌棎電� 鞙犿喌 欤检嫕靾橁皜 223,245,915欤茧 旮办灛霅橃柎 鞛堦碃, 毵る弰 鞓堨爼鞚检潃 NASDAQ鞐愳劀 2025-08-29搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 歃濌秾鞚� 氚滍枆鞚胳溂搿滊秬韯� 2025-08-28鞐� 鞝滍暅欤茧 旆摑霅橃棃瓿�, 歆�旮夓澕霃� 2025-08-28搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛愲姅 歆�雮� 3臧滌洈 霃欖晥 歃濌秾鞚� 毵る弰頃� 靷嫟鞚� 鞐嗢潓鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 韺愲Г鞛愱皜 氙戈车臧滌潣 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞚胳頃橁碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹鞚� 韽暔霅橃柎 鞛堨溂氅�, 頃措嫻霅橂姅 瓴届毎 攴滌箼 10b5-1 瓯半灅 瓿勴殟鞐� 鞚橃〈頃� 臧�電レ劚霃� 鞏戈笁霅橃柎 鞛堨姷雼堧嫟. 瓿店皽霅� 雮挫毄鞐愲姅 氚滍枆鞚� 鞚措瓿� 鞚茧秬 鞝滌稖鞛� 鞐半澖觳橁皜 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Formulaire 144 d茅pos茅 pour Viavi Solutions Inc. (VIAV) indique une proposition de vente de 13 115 actions ordinaires via Morgan Stanley Smith Barney LLC, pour une valeur de march茅 totale de 146 560,13 USD. Le d茅p么t mentionne 223 245 915 actions en circulation et identifie la date approximative de vente au 29/08/2025 sur le NASDAQ. Les titres ont 茅t茅 acquis le 28/08/2025 en tant qu'actions restreintes de l'茅metteur, avec paiement dat茅 du 28/08/2025. Le d茅clarant indique ne pas avoir vendu de titres au cours des trois derniers mois. Le dossier comprend la d茅claration standard selon laquelle le vendeur n'est pas au courant d'informations d茅favorables mat茅rielles non divulgu茅es et 茅voque la possibilit茅 de recourir 脿 un plan de n茅gociation en vertu de la r猫gle 10b5-1, le cas 茅ch茅ant. Le nom de l'茅metteur et certains contacts du d茅clarant ne figurent pas dans le contenu visible.
Formular 144 eingereicht f眉r Viavi Solutions Inc. (VIAV) weist auf einen geplanten Verkauf von 13.115 Stammaktien 眉ber Morgan Stanley Smith Barney LLC hin, mit einem Gesamtmarktwert von 146.560,13 USD. Die Einreichung listet 223.245.915 ausstehende Aktien und nennt den ungef盲hren Verkaufszeitpunkt am 29.08.2025 an der NASDAQ. Die Wertpapiere wurden am 28.08.2025 als eingeschr盲nkte Aktien vom Emittenten erworben, die Zahlung ist auf den 28.08.2025 datiert. Der Einreicher gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben. Die Einreichung enth盲lt die 眉bliche Erkl盲rung, dass dem Verk盲ufer keine nicht offengelegten erheblichen nachteiligen Informationen bekannt sind, und erw盲hnt gegebenenfalls die m枚gliche Nutzung eines Rule-10b5-1-Handelsplans. Im sichtbaren Inhalt fehlen der Name des Emittenten sowie einige Kontaktdaten des Einreichers.
- Execution via a registered broker: The proposed sale is to be handled by Morgan Stanley Smith Barney LLC
- No recent sales reported: The filer reports "Nothing to Report" for securities sold in the past three months
- Issuer name absent in provided excerpt: The filing content does not display the issuer name in the visible sections
- Very short interval between acquisition and proposed sale: Securities were acquired on 08/28/2025 and the approximate sale date is 08/29/2025
Insights
TL;DR: Small insider sale notice for 13,115 shares via a major broker, acquired as restricted stock one day before the proposed sale.
The filing documents a proposed Rule 144 sale of 13,115 common shares valued at $146,560.13, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ. The securities were recorded as acquired from the issuer on 08/28/2025 as restricted stock with payment on the same date and an intended sale on 08/29/2025. The filer reports no sales in the prior three months. For investors, this is a routine insider notice describing a planned sale under Rule 144; the filing itself contains no performance metrics or forward-looking company data.
TL;DR: The notice reflects a compliance filing for resale of recently acquired restricted shares, with standard seller certification.
The document includes the seller's representation that they lack undisclosed material adverse information and references Rule 10b5-1 plan adoption language. The transaction is routed through an institutional broker, and the filer indicates no other disposals in the past three months. One governance note: the visible content does not show the issuer name or complete filer contact details, which limits transparency in this excerpt.
Modulo 144 presentato per Viavi Solutions Inc. (VIAV) indica una proposta di vendita di 13.115 azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di 146.560,13 USD. La comunicazione riporta 223.245.915 azioni in circolazione e segnala come data approssimativa di vendita il 29/08/2025 sul NASDAQ. I titoli sono stati acquisiti il 28/08/2025 come azioni vincolate dall'emittente, con pagamento datato 28/08/2025. Il dichiarante segnala di non aver venduto titoli nei tre mesi precedenti. Nel documento 猫 inclusa la consueta dichiarazione secondo cui il venditore non 猫 a conoscenza di informazioni materiali avverse non divulgate e si menzionano eventuali dipendenze da un piano di negoziazione ai sensi della Regola 10b5-1, se applicabile. Nell'estratto visibile non sono riportati il nome completo dell'emittente e alcuni recapiti del dichiarante.
Formulario 144 presentado para Viavi Solutions Inc. (VIAV) muestra una propuesta de venta de 13.115 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de 146.560,13 USD. La presentaci贸n indica 223.245.915 acciones en circulaci贸n y se帽ala la fecha aproximada de venta como el 29/08/2025 en NASDAQ. Los valores fueron adquiridos el 28/08/2025 como acciones restringidas por el emisor, con pago con fecha 28/08/2025. El declarante informa que no ha vendido valores en los 煤ltimos tres meses. El expediente incluye la representaci贸n habitual de que el vendedor no conoce informaci贸n material adversa no divulgada y menciona la posible dependencia de un plan de negociaci贸n conforme a la Regla 10b5-1, si procede. En el contenido visible no aparecen el nombre del emisor ni algunos datos de contacto del declarante.
Viavi Solutions Inc. (VIAV)鞐� 雽�頃� 鞏戩嫕 144 鞝滌稖鞚� Morgan Stanley Smith Barney LLC毳� 韱淀暣 13,115欤� 氤错喌欤� 毵る弰毳� 鞝滌晥頄堨溂氅�, 齑� 鞁滉皜 臧�旃橂姅 146,560.13雼煬搿� 雮橅儉雮╇媹雼�. 鞝滌稖靹滌棎電� 鞙犿喌 欤检嫕靾橁皜 223,245,915欤茧 旮办灛霅橃柎 鞛堦碃, 毵る弰 鞓堨爼鞚检潃 NASDAQ鞐愳劀 2025-08-29搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 歃濌秾鞚� 氚滍枆鞚胳溂搿滊秬韯� 2025-08-28鞐� 鞝滍暅欤茧 旆摑霅橃棃瓿�, 歆�旮夓澕霃� 2025-08-28搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛愲姅 歆�雮� 3臧滌洈 霃欖晥 歃濌秾鞚� 毵る弰頃� 靷嫟鞚� 鞐嗢潓鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 韺愲Г鞛愱皜 氙戈车臧滌潣 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞚胳頃橁碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹鞚� 韽暔霅橃柎 鞛堨溂氅�, 頃措嫻霅橂姅 瓴届毎 攴滌箼 10b5-1 瓯半灅 瓿勴殟鞐� 鞚橃〈頃� 臧�電レ劚霃� 鞏戈笁霅橃柎 鞛堨姷雼堧嫟. 瓿店皽霅� 雮挫毄鞐愲姅 氚滍枆鞚� 鞚措瓿� 鞚茧秬 鞝滌稖鞛� 鞐半澖觳橁皜 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Formulaire 144 d茅pos茅 pour Viavi Solutions Inc. (VIAV) indique une proposition de vente de 13 115 actions ordinaires via Morgan Stanley Smith Barney LLC, pour une valeur de march茅 totale de 146 560,13 USD. Le d茅p么t mentionne 223 245 915 actions en circulation et identifie la date approximative de vente au 29/08/2025 sur le NASDAQ. Les titres ont 茅t茅 acquis le 28/08/2025 en tant qu'actions restreintes de l'茅metteur, avec paiement dat茅 du 28/08/2025. Le d茅clarant indique ne pas avoir vendu de titres au cours des trois derniers mois. Le dossier comprend la d茅claration standard selon laquelle le vendeur n'est pas au courant d'informations d茅favorables mat茅rielles non divulgu茅es et 茅voque la possibilit茅 de recourir 脿 un plan de n茅gociation en vertu de la r猫gle 10b5-1, le cas 茅ch茅ant. Le nom de l'茅metteur et certains contacts du d茅clarant ne figurent pas dans le contenu visible.
Formular 144 eingereicht f眉r Viavi Solutions Inc. (VIAV) weist auf einen geplanten Verkauf von 13.115 Stammaktien 眉ber Morgan Stanley Smith Barney LLC hin, mit einem Gesamtmarktwert von 146.560,13 USD. Die Einreichung listet 223.245.915 ausstehende Aktien und nennt den ungef盲hren Verkaufszeitpunkt am 29.08.2025 an der NASDAQ. Die Wertpapiere wurden am 28.08.2025 als eingeschr盲nkte Aktien vom Emittenten erworben, die Zahlung ist auf den 28.08.2025 datiert. Der Einreicher gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben. Die Einreichung enth盲lt die 眉bliche Erkl盲rung, dass dem Verk盲ufer keine nicht offengelegten erheblichen nachteiligen Informationen bekannt sind, und erw盲hnt gegebenenfalls die m枚gliche Nutzung eines Rule-10b5-1-Handelsplans. Im sichtbaren Inhalt fehlen der Name des Emittenten sowie einige Kontaktdaten des Einreichers.
FAQ
What is being sold in the VIAV Form 144?
When is the proposed sale date listed in the filing?
Through which broker will the VIAV shares be sold?
How were the securities acquired according to the filing?
Does the filer report recent sales of VIAV stock?
